Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation

Area of Science:

• Neuroscience
• Vascular Biology
• Genetics

Background:

• Cerebral cavernous malformations (CCMs) are neurovascular lesions linked to mutations in KRIT1, CCM2, or PDCD10.
• CCMs have been primarily considered endothelial cell-autonomous diseases.

Purpose of the Study:

• To investigate the role of astrocytes in CCM pathogenesis.
• To identify molecular mechanisms driving CCM lesion formation.
• To explore potential therapeutic targets for CCMs.

Main Methods:

• Investigated astrocyte proliferation and VEGF production in CCM models.
• Analyzed the role of endothelial nitric oxide (NO) and KLF factors.
• Examined the stabilization of HIF-1α in astrocytes.
• Assessed the impact of cyclooxygenase-2 (COX-2) inhibition on CCM lesion progression.

Main Results:

• Proliferative astrocytes are a major source of VEGF during CCM lesion development.
• Endothelial NO, induced by KLF2/KLF4 and eNOS, increases astrocyte VEGF synthesis.
• Endothelial NO stabilizes HIF-1α in astrocytes, inducing a "hypoxic" program.
• COX-2 upregulation contributes to CCM lesions; COX-2 inhibition prevents lesion progression.

Conclusions:

• Non-cell-autonomous interactions between endothelial cells and astrocytes are crucial for CCM development.
• Components of the hypoxic program, like COX-2, are viable therapeutic targets for CCMs.